title: New Cancer Drugs Fund is flawed without NICE reform, says Roche.
authors.affiliation: London.
authors.forename: Nigel
authors.initials: N
authors.lastname: Hawkes
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics / Q000600:supply & distribution*; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D004345:Drug Industry; D004739:England; D006077:Government Agencies; D006801:Humans; D013222:State Medicine / Q000191:economics
chemical_list: D000970:Antineoplastic Agents